LDOS vs NVDA

Leidos (LDOS) presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but not strong financial health. While the company exhibits exceptional profitability with an ROE of 31.03% and a low P/E of 13.12, it is currently battling negative revenue growth (-3.60%) and a severe bearish technical trend (0/100). The significant gap between the Graham Number ($98.74) and the growth-based Intrinsic Value ($328.63) suggests the market is struggling to price the company's transition from revenue expansion to margin optimization. Despite consistent earnings beats, the combination of insider selling and negative top-line growth warrants a neutral stance.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.